109 related articles for article (PubMed ID: 17213681)
21. Antinociceptive effects of galanin in the central nucleus of amygdala of rats, an involvement of opioid receptors.
Jin WY; Liu Z; Liu D; Yu LC
Brain Res; 2010 Mar; 1320():16-21. PubMed ID: 20051236
[TBL] [Abstract][Full Text] [Related]
22. Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.
Makino M; Kitano Y; Komiyama C; Hirohashi M; Takasuna K
Br J Pharmacol; 2000 Jul; 130(6):1269-74. PubMed ID: 10903965
[TBL] [Abstract][Full Text] [Related]
23. Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
Silva RM; Grossman HC; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 2002 May; 301(2):513-8. PubMed ID: 11961051
[TBL] [Abstract][Full Text] [Related]
24. Discriminative stimulus properties of morphine mediated by mu 1-opioid receptors.
Suzuki T; Mori T; Tsuji M; Misawa M; Nagase H
Eur J Pharmacol; 1995 Sep; 284(1-2):195-8. PubMed ID: 8549626
[TBL] [Abstract][Full Text] [Related]
25. Analysis of central opioid receptor subtype antagonism of hypotonic and hypertonic saline intake in water-deprived rats.
Bodnar RJ; Glass MJ; Koch JE
Brain Res Bull; 1995; 36(3):293-300. PubMed ID: 7697383
[TBL] [Abstract][Full Text] [Related]
26. Effects of various mu- and delta-opioid ligands on food intake in the meat-type chick.
Bungo T; Dodo K; Kawamura K; Izumi T; Ueda H
Physiol Behav; 2005 Aug; 85(5):519-23. PubMed ID: 16054662
[TBL] [Abstract][Full Text] [Related]
27. Involvement of mu1 and mu2 opioid receptor subtypes in tail-pinch feeding in rats.
Koch JE; Bodnar RJ
Physiol Behav; 1993 Mar; 53(3):603-5. PubMed ID: 8383858
[TBL] [Abstract][Full Text] [Related]
28. Functional interactions between delta- and mu-opioid receptors in rat thermoregulation.
Salmi P; Kela J; Arvidsson U; Wahlestedt C
Eur J Pharmacol; 2003 Jan; 458(1-2):101-6. PubMed ID: 12498912
[TBL] [Abstract][Full Text] [Related]
29. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the mu-opioid receptors on SH-SY5Y cells using beta-funaltrexamine (beta-FNA) and naloxonazine.
Elliott J; Smart D; Traynor JR; Lambert DG
Biochem Soc Trans; 1993 Nov; 21(4):469S. PubMed ID: 8132037
[No Abstract] [Full Text] [Related]
31. A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat.
Stromberg MF; Casale M; Volpicelli L; Volpicelli JR; O'Brien CP
Alcohol; 1998 May; 15(4):281-9. PubMed ID: 9590512
[TBL] [Abstract][Full Text] [Related]
32. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
33. Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats.
Beczkowska IW; Koch JE; Bostock ME; Leibowitz SF; Bodnar RJ
Brain Res; 1993 Aug; 618(2):261-70. PubMed ID: 8397050
[TBL] [Abstract][Full Text] [Related]
34. Subclass opioid receptors associated with the cardiovascular depression after traumatic shock and the antishock effects of its specific receptor antagonists.
Liu LM; Hu DY; Pan XK; Lu RQ; Dan FJ
Shock; 2005 Nov; 24(5):470-5. PubMed ID: 16247334
[TBL] [Abstract][Full Text] [Related]
35. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Wang D; Sun X; Sadee W
J Pharmacol Exp Ther; 2007 May; 321(2):544-52. PubMed ID: 17267582
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological effects of naltriben as a ligand for opioid mu and kappa receptors in rat cerebral cortex.
Kim KW; Son Y; Shin BS; Cho KP
Life Sci; 2001 Feb; 68(11):1305-15. PubMed ID: 11233997
[TBL] [Abstract][Full Text] [Related]
38. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.
Gray AC; White PJ; Coupar IM
Br J Pharmacol; 2005 Mar; 144(5):687-94. PubMed ID: 15678085
[TBL] [Abstract][Full Text] [Related]
40. Intramuscular administration of morphine reduces mustard-oil-induced craniofacial-muscle pain behavior in lightly anesthetized rats.
Han SR; Lee MK; Lim KH; Yang GY; Jeon HJ; Ju JS; Yoon YW; Kim SK; Ahn DK
Eur J Pain; 2008 Apr; 12(3):361-70. PubMed ID: 17768078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
